Introduction
============

Quantitative measurement of *in vivo* multicomponent T~2~ relaxation in the central nervous system (CNS) can provide information about pathophysiology based on different water environments in tissues. Myelin is a fatty insulating substance that envelops the axons in the CNS and plays a fundamental role in enabling saltatory conduction and directly supplying energy to axons ([@B25]; [@B17]). Quantitative *in vivo* imaging of myelin, using magnetic resonance imaging (MRI), can enhance our understanding about the pathological processes in demyelinating diseases, such as multiple sclerosis (MS), as well as improve the clinical diagnosis, prognosis and disease management process ([@B15]; [@B10]; [@B27]; [@B11], [@B12]; [@B22]).

Myelin water imaging (MWI) can be achieved using multi-component T~2~ relaxation analysis to quantify the MR signals from different water compartments within a voxel ([@B21], [@B20]; [@B40]). Healthy tissue in the CNS typically contains cerebrospinal fluid (long T~2~ component of \>2000 ms), intra- and extracellular water (intermediate T~2~ component of ∼70 ms) and myelin water in between myelin bilayers (short T~2~ component of ∼15 ms) ([@B21]; [@B40]). The myelin water fraction (MWF), the ratio of the short T~2~ component (myelin water) to the total T~2~ distribution, shown as the voxel values in MWI, has been used as an *in vivo* marker of myelin content in the CNS ([@B21], [@B20]; [@B40]). MWF has been shown to strongly correlate with histological measures using myelin-specific staining in rats ([@B38]; [@B26]; [@B31]), guinea pigs ([@B6], [@B7]) and postmortem human brains ([@B24]; [@B14]). MWI has been widely used to study white matter (WM) abnormalities in MS ([@B35]; [@B16]; [@B12]), schizophrenia ([@B5]), phenylketonuria ([@B32]) and traumatic brain injury ([@B42]).

To effectively apply MWI in multicenter studies and clinically, MWF measurements must be reproducible across sites and scanner vendors. Recently, a combined gradient and spin echo (GRASE) sequence was adopted for MWI, reducing the acquisition time to less than 15 min for full cerebral coverage (20 slices at 5 mm thickness) ([@B30]).

Previously, [@B23] assessed the reproducibility of MWI with partial brain coverage (7 slices at 5 mm thickness, acquisition time = 18.5 min) in five healthy participants across six sites using a 3D spin echo sequence acquired on 3 T Philips scanners. They demonstrated a good reproducibility of the MWF in the global white matter (WM; intersite coefficient of variation (COV) = 4.68%) ([@B23]). The present study follows the methodology of [@B23] but improves on the acquisition technique by using the recently developed rapid whole cerebrum GRASE MWI sequence ([@B30]) and including 3 T scanners from different vendors. In this study, we assess the reproducibility of MWF measurements in regional and global WM across two sites with different scanner vendors using a 3D GRASE sequence. Demonstrating reproducibility across scanner vendors with a rapid whole brain acquisition technique will bring MWI one step closer to routine use for multisite studies and clinical applications.

Materials and Methods {#s1}
=====================

Participant Information
-----------------------

Ten healthy participants (six males and four females; mean age 36.5 years, range 21--53 years) were scanned across two sites with different 3 T MRI scanner vendors. The mean time between the two scans was 26 days (range 5--62 days). All participants had no previously known neurological disorders or brain abnormalities. The study was approved by the Research Ethics Boards at both institutions and all participants provided written informed consent prior to participation.

Data Acquisition
----------------

MRI data were acquired from each participant on a Siemens Magnetom Trio 3 T (Siemens Medical Solutions, Erlangen, Germany) with 32-channel head coil at Seoul National University, Republic of Korea (site 1) and a Philips Achieva 3 T (Philips Medical Systems, Best, The Netherlands) with an 8-channel head coil at the University of British Columbia, Canada (site 2). T~1~-weighted anatomical images were acquired at each site using a whole-brain 3D magnetization-prepared rapid gradient-echo (MP-RAGE) sequence to facilitate automated tissue segmentation and spatial normalization. MWI data were acquired using a whole-brain, multi-echo 3D GRASE sequence ([@B30]). We were not able to exactly match acquisition parameters at each site due to differences in sequence implementation between the two sites and vendors. Therefore, we chose to use protocols that were standard practice for each site (i.e., that were the most commonly used for ongoing research studies or clinical examinations within that center and which would be representative sample for a future multicenter study), which were as follows:

1.  Site 1 GRASE: 32 echoes, TE = 10, 20, 30, ... 320 ms, TR = 1000 ms, 5 mm slice thickness, 30 slices, slice partial Fourier factor = 5/8, acquisition time = 12 min, 1.5 × 1.5 mm^2^ in-plane resolution.

2.  Site 1 MP-RAGE: TR = 2400 ms, TE = 2.12 ms, TI = 1000 ms, 1 × 1× 1 mm^3^, α = 8°.

3.  Site 2 GRASE: 32 echoes, TE = 10, 20, 30, ... 320 ms, TR = 1000 ms, 5 mm slice thickness, 20 slices (40 slices reconstructed at 2.5 mm slice thickness), SENSE factor of 2, acquisition time = 14 min, 1 × 1 mm^2^ in-plane resolution.

4.  Site 2 MP-RAGE: TR = 3000 ms, TE = 3.00 ms, TI = 820 ms, 1 × 1 × 1.6 mm^3^, α = 8°.

T~2~ Decay Curve Analysis
-------------------------

The 32-echo GRASE sequence produced a T~2~ decay curve in each voxel, which was analyzed using a regularized non-negative least squares (NNLS) algorithm with stimulated echo correction ([@B39]; [@B29]) to obtain the T~2~ distribution (*T*~2~ = 0.015--2 s) for each voxel. The stimulated echo correction adjusts for errors in the refocusing flip angle due to B~1~ inhomogeneity. The extended phase graph algorithm ([@B29]) was used to calculate a theoretical T~2~ decay curve for non-ideal refocusing pulse flip angle. It then estimated the true refocusing flip angle by comparing theoretical decay curves with eight potential refocusing pulse flip angles linearly spaced from 50 to 180 degrees, to the experimental decay. Using the optimal refocusing pulse flip angle, a T~2~ distribution (40 logarithmically spaced *T*~2~ values from 0.015--2 s) was obtained using NNLS for each voxel. The short T~2~ component attributed to myelin water was identified as 15--40 ms. T~2~ analysis was performed using in-house software code (MATLAB R2013b, The Mathworks, Inc.) developed at the University of British Columbia.

Global White Matter and Regions of Interest Analyses
----------------------------------------------------

The MP-RAGE image was linearly registered and transformed to the first echo of the GRASE data from the same site using FMRIB's Linear Image Registration Tool (FLIRT) ([@B9]; [@B33]). Second, the transformed MP-RAGE image was registered to the MNI-152 2 mm template using a non-linear registration process implemented in FMRIB's Non-Linear Image Registration Tool (FNIRT) ([@B33]; [@B1]) to obtain the non-linear warp-field between GRASE and MNI-152 space.

Five white matter regions of interest (ROI), including the genu and splenium of the corpus callosum, major and minor forceps, and superior longitudinal fasciculus were obtained from JHU DTI-based white-matter atlases in MNI-152 space (Figure [1](#F1){ref-type="fig"}) and transformed to GRASE space using the inverse of the previously obtained non-linear warp-field ([@B37]; [@B8]). All ROI were then multiplied by the global WM mask, thresholded and binarized to generate more conservative ROI masks. They were further manually edited when necessary to remove non-WM voxels and to ensure same coverage between the two scans for all participants.

![An example of masks of the global WM (red) and ROI, including the splenium (light blue) and genu (purple) of the corpus callosum, superior longitudinal fasciculus (yellow), minor forceps (green), and major forceps (dark blue) on axial T~1~-weighted anatomical image of Participant 1.](fnins-12-00854-g001){#F1}

A global WM mask was obtained from the MP-RAGE using FMRIB's Automated Segmentation Tool (FAST; Figure [1](#F1){ref-type="fig"}) and subsequently transformed to the native space of the GRASE data using the linear transformation obtained from the first step in the registration process described above ([@B43]; [@B33]). The WM mask was then thresholded, eroded, binarized, and edited when necessary to ensure that non-WM voxels were removed and that the coverage was the same for all participants.

Statistical Analysis
--------------------

To assess reproducibility, Pearson's correlation coefficient (*r*) was calculated using the mean MWF from the global WM of each participant at site 1 and site 2. A *p*-value was calculated from the Pearson's *r* to determine if the correlation was significant. Statistical significance for all comparisons were defined as *p* \< 0.05. A paired *t*-test was performed to determine if there was a difference in mean MWF between two sites. In addition, an equivalence test, two one-sided test (TOST), was performed to determine whether mean MWF between two sites were statistically equivalent. TOST prevents potential misinterpretation of non-significant *p*-values obtained from the paired *t*-test as the absence of a practically important effect. The 95% confidence interval for the estimated difference between the sites is also used to indicate the smallest difference that would have been detectable. The COV was calculated by dividing the standard deviation by the mean, of the two sites, for each ROI and global WM per participant. The COV is biased to lower values when the number of points (*n*) used to calculate COV is small. To correct for this, the sample COV was multiplied by \[1 + 1/(4^∗^*n*)\] as suggested by [@B23]. Here, *n* = 2 so the sample COV was multiplied by 1.13. The corrected COVs were averaged across all participants. Finally, Bland-Altman analysis was used to assess the agreement in MWF between the two sites. All statistical analyses were performed using the R software package.

Results
=======

MWF maps of 10 healthy participants from the two sites are illustrated in Figure [2](#F2){ref-type="fig"}. Tables [1](#T1){ref-type="table"} and [2](#T2){ref-type="table"} display the mean intersite MWF COVs in the global WM and ROI for each participant. The mean intersite MWF COV averaged across the participants was low (2.77%, range 0.03--8.00%). The mean intersite MWF COV was the highest in the genu (17.89%) and lowest in the splenium (4.47%) of the corpus callosum (Table [2](#T2){ref-type="table"}).

![MWF maps from 10 healthy participants from site 1 (top) and site 2 (bottom).](fnins-12-00854-g002){#F2}

###### 

Intersite MWF COVs in the global WM for each participant.

  Participant   MWF COV (%)
  ------------- -------------
  1             0.03
  2             1.01
  3             1.03
  4             1.04
  5             1.98
  6             2.51
  7             2.53
  8             3.46
  9             6.11
  10            8.00
  Mean          2.77

###### 

Summary of mean intersite MWF COVs in the global WM and ROI averaged across 10 participants.

  ROI                                Mean intersite MWF COV (%)
  ---------------------------------- ----------------------------
  Splenium of the corpus callosum    4.47
  Superior longitudinal fasciculus   10.86
  Minor forceps                      12.71
  Major forceps                      6.63
  Genu of the corpus callosum        17.89
  Global white matter                2.77

A strong correlation was observed between the mean MWF in the global WM at each site (Pearson's *r* = 0.91, *p* \< 0.001) (Figure [3](#F3){ref-type="fig"}). The estimated difference between sites for the global WM was −0.002. A paired *t*-test was not statistically significant (*t* = −1.480, *p* = 0.173) with a 95% confidence interval of −0.005--0.001 indicating that the smallest detectable difference would have been 0.003. Based on the equivalence test, the observed estimated effect of −0.002 was statistically equivalent to zero (*p* = 0.03). This test was based on equivalence bounds of −0.005 and 0.005, an alpha of 0.05 and the 90% confidence interval of −0.0047--0.0005. The variation in the MWF measurements in the global WM between the two sites was not associated with a longer time between the two scans (mean time between the scans = 26 days, range 5--62 days; *r* = 0.14, *p* = 0.70). The mean MWF for the individual ROI are shown in Figure [4](#F4){ref-type="fig"} as a scatter plot. There was a high correlation between the mean MWF in the genu (*r* = 0.75, *p* = 0.01) and splenium (*r* = 0.97, *p* \< 0.001) of the corpus callosum, major forceps (*r* = 0.73, *p* = 0.02), minor forceps (*r* = 0.82, *p* = 0.003) and superior longitudinal fasciculus (*r* = 0.76, *p* = 0.01) at each site (Figure [4](#F4){ref-type="fig"}).

![Correlation plot of mean MWF **(A)** and Bland--Altman plot comparing MWF measurements **(B)** between site 1 and site 2 in the global WM mask across 10 healthy participants. The solid line represents the slope of the MWF data and the dashed line represents y = x, which indicates 1:1 agreement, on the correlation plot **(A)**. The black solid line represents the average difference (bias), the black dashed lines indicate the limits of agreement (±1.96 standard deviation) and the orange dashed line indicates the linear fit to the data point **(B)**.](fnins-12-00854-g003){#F3}

![Mean MWF measurements between site 1 and site 2 in genu **(A)** and splenium of the corpus callosum **(B)**, major forceps **(C)**, minor forceps **(D)** and superior longitudinal fasciculus **(E)** across 10 healthy participants.](fnins-12-00854-g004){#F4}

Bland-Altman analysis showed good agreement in the MWF measurements in the global WM between the two sites (Figure [3](#F3){ref-type="fig"}). There was a very small bias of 0.002 with the upper limit of agreement (+1.96 standard deviation) of 0.011 and lower limit of agreement (−1.96 standard deviation) of −0.007. The data points were distributed evenly around the bias, as indicated by the non-significant slope (*p* = 0.96) (Figure [3](#F3){ref-type="fig"}).

Discussion
==========

In this study, we extended previous findings from a multisite and single-vendor study of MWF reproducibility ([@B23]). We assessed the reproducibility of MWF at two different sites using MR scanners of different vendors (Siemens and Philips) and found good intersite global WM mean MWF reproducibility indicated by a low COV (mean 2.77%, range 0.03--8.00%), high Pearson's correlation coefficient (*r* = 0.91, *p* \< 0.001) and very small bias (mean bias = 0.002). The COV remained low when comparing the 25th (6.04%) and 75th percentile (4.27%) of MWF in global WM across all participants between sites. In comparison, [@B23] found an intersite mean MWF COV (mean 4.68%, range 2.86--8.14%) in the global WM for five healthy participants scanned at six sites using the same MR scanner vendor. [@B23] also showed wider bands between the mean bias and ± 1.96 standard deviation (−0.014--0.016) on Bland--Altman plot, which indicates a greater uncertainty compared to our study (−0.007--0.011). Assuming the true mean difference is the worst case of −0.005, the lower boundary of the 95% confidence interval from a paired *t*-test, this gives a ±4.74% change on average based on our MWF data for global WM. Based on our equivalence bounds, this is equivalent to worst case ±4.74% change between sites. To put into perspective, previous studies have reported that mean MWF was 16--37% lower in the normal-appearing WM of MS compared to WM of healthy controls ([@B15]; [@B4]; [@B3]). Flynn et al found that mean MWF was 12% lower in the overall WM in schizophrenia compared to healthy controls ([@B5]). Given the small sample size, the magnitude of difference is uncertain so we recommend taking the effect of center or machine into account when doing the analysis in multicenter studies.

While the intersite MWF reproducibility from regional ROI remained high (COV range 4.47--17.89%), frontal brain regions, including genu (17.89%) and minor forceps (12.71%), showed higher variability than others, possibly due to artifact caused by susceptibility, flow and motion. As a comparison, [@B23] reported intersite MWF COV of 15.67 and 17.18% in genu and minor forceps, respectively, using the same MR scanner vendor. The air-filled sinuses produce differences in the tissue magnetic susceptibility resulting in local magnetic field inhomogeneities; it is still unclear how this will affect our quantitative measurements. Furthermore, the genu is located near the frontal horn of the lateral ventricle containing cerebrospinal fluid, which pulsates with the cardiac cycle, which again could introduce artifacts in our measurements.

A power analysis using the G^∗^ Power 3.1 program indicated that based on our pilot study results, for a larger trial, a total sample of 46 people would be needed to detect medium effect size (Cohen's *d* = 0.49) with 90% power using a paired *t*-test between means with alpha at 0.05. A total sample of 35 people would be needed to achieve 80% power with the same effect size and alpha.

Previous multi-echo T~2~ reproducibility studies using a single vendor scanner have shown good to moderate reproducibility of myelin content measurements ([@B34]; [@B18]; [@B23]). The data acquired for our study differs from the previous MWF reproducibility studies in several aspects. Our study was performed on 3 T scanners, which improved signal-to-noise in the decay curve by almost 100% compared to 1.5 T ([@B13]). The GRASE sequence used in this study ([@B30]) can be acquired in a clinically feasible time (under 15 min) compared to a single-slice multi-echo spin echo acquisition (1 slice in 26 min) ([@B21]). Another advantage of the GRASE acquisition is that data is collected in 3D. This avoids potential magnetization transfer effects between slices that could occur in 2D multi-slice acquisition, which can affect the MWF ([@B36]). To account for B~1~ inhomogeneity, stimulated echo correction was applied to correct for errors in refocusing flip angle ([@B29]), which will improve the robustness of the analysis. We also studied both regional and global WM. Finally, and most importantly, we studied reproducibility across two scanner vendors located at two sites.

In this study, we were interested in studying the reproducibility of the MWF across two different sites, each using their standard of practice MWI sequence. We believe this best reflects a future multicenter study where the inevitable slight differences between vendors make it impractical to match all sequence parameters as well as hardware. As a consequence of this, different in-plane resolution and imaging acceleration were used at the two sites in this study. Both of these parameters are likely to affect the signal to noise ratio (SNR) of the acquisition. Furthermore, the use of partial k-space acceleration on the Siemens scanner in comparison to parallel imaging on the Philips scanner can also affect the image quality. Another factor that will contribute to differences in SNR between the two sites is the use of different radiofrequency (RF) receiver coils. The Siemens site used a 32-channel coil compared to the 8-channel coil at the Philips site. A larger number of channels in the coil will intrinsically lead to higher SNR and lower g-factor for parallel imaging; however, we would not expect any drastic differences considering that parallel imaging was not used on the Siemens site and acceleration factor of 2 was used on the Philips site ([@B41]).

Previous studies have investigated the effect of SNR on the MWF through simulations and found that the MWF may be underestimated at low SNR ([@B2]). In this study, we do not find any results that would support the hypothesis that differences in SNR between the two sites, due to differences in hardware and acquisition, cause significant differences in the MWF. This is an important result, indicating that the MWF estimates are reasonably robust to differences in both hardware and acquisition parameters.

Another limitation of the present study is the small sample size of only 10 participants. Also, scan-rescan data at each site were not collected in this study. However, previous studies that acquired a multi-echo spin echo sequence in brain (mean intrasite MWF COV = 3.99%) ([@B23]) and GRASE-derived MWI in spinal cord ([@B19]) using Philips Achieva 3 T reported good scan-rescan intrasite repeatability, suggesting robustness of the technique. Further, another study that acquired a GRASE-derived MWI in brain ([@B28]) using a Siemens Magnetom Trio 3 T also reported good scan-rescan intrasite repeatability (mean correlation coefficient = 0.88 ± 0.03).

Conclusion
==========

This study showed good reproducibility of MWF measurements between two sites with MRI scanners from different vendors. The intersite variability was comparable to previous results using a single MRI scanner vendor ([@B23]), without significant bias between sites. Thus, our results support the future use of MWI in studies involving multiple centers and different scanner vendors. Acquiring MWF data across larger groups and populations will allow us to gain deeper insight into pathological processes due to underlying disease progression in demyelinating diseases like MS, which may not be possible with conventional MRI.

Author Contributions
====================

LL and EL coordinated the study, recruited the participants, collected and analyzed the data, interpreted the results, and drafted the manuscript for intellectual content. DS coordinated the study, collected the data, and revised the manuscript for intellectual content. CF, IV, AR, JC-A, DL, AT, and AM interpreted the results and revised the manuscript for intellectual content. JL designed the study, obtained funding for the data analysis, interpreted the results, and revised the manuscript for intellectual content. SK designed and conceptualized the study, supervised the data analysis, obtained funding for data analysis, interpreted the results, and revised the manuscript for intellectual content.

Conflict of Interest Statement
==============================

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

**Funding.** This research was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2015R1D1A1A01058350). This research was also supported by the UBC MRI Research Group and Milan & Maureen Ilich Foundation.

We would like to sincerely thank all participants and the MR technologists at the UBC MRI Research Centre. We also thank Dr. Cornelia Laule for helping with recruitment of participants, Ms. Sumeet Mutti for helpful discussion and Dr. Carolyn Taylor, Dr. Biljana Jonoska Stojkova and Ms. Maria del Mar Bazua-Lobato for statistical advice.

[^1]: Edited by: Andrew L. Alexander, University of Wisconsin--Madison, United States

[^2]: Reviewed by: Eva Alonso Ortiz, The Ottawa Hospital, Canada; Steffen Bollmann, The University of Queensland, Australia

[^3]: ^†^These authors have contributed equally to this work

[^4]: This article was submitted to Brain Imaging Methods, a section of the journal Frontiers in Neuroscience
